11:10 AM EDT, 07/22/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.69% to 1,924.81 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and petroleum refiner Equinor ( EQNR ) , which climbed 6.8% and 4.9%, respectively. They were followed by semiconductor company Sequans Communications ( SQNS ) and brewing company Anheuser-Busch InBev ( BUD ) , which advanced 4% and 2.8%, respectively.

The decliners from continental Europe were led by internet browser company Opera (OPRA) and biopharmaceutical company DBV Technologies ( DBVT ) , which dropped 3.3% and 2.9%, respectively. They were followed by telecommunications company Nokia ( NOK ) and software firm SAP (SAP), which lost 2.6% and 2%, respectively.

The gainers from the UK were led by biopharmaceutical firm Akari Therapeutics ( AKTX ) and insurance firm Prudential (PUK), which rose 6.6% and 3.4%, respectively. They were followed by lender HSBC ( HSBC ) and telecommunications company operator Vodafone Group ( VOD ) , which were up 2.2% each.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which shed 21% and 2.8% respectively. They were followed by pharmaceutical company Silence Therapeutics ( SLN ) and educational publisher Pearson (PSO), which fell 1.2% and 0.8% respectively.